Is antiepileptic drug use related to depression and suicidal ideation among patients with epilepsy?

Epilepsy and Behavior

Volumn 19, Issue 3, 2010, Pages 494-500

  Wen, X ^a   Meador, K J ^b   Loring, D W ^b   Eisenschenk, S ^a   Segal, R ^a   Hartzema, A G ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antiepileptic drugs; Depression; Epilepsy; Suicidality; Suicide

Indexed keywords

AMITRIPTYLINE; ANTICONVULSIVE AGENT; CARBAMAZEPINE; CITALOPRAM; CLONAZEPAM; DULOXETINE; ESCITALOPRAM; ETHOSUXIMIDE; ETIRACETAM; FELBAMATE; GABAPENTIN; LAMOTRIGINE; LORAZEPAM; OXCARBAZEPINE; PAROXETINE; PHENOBARBITAL; PHENYTOIN; PREGABALIN; QUETIAPINE; SERTRALINE; TIAGABINE; TOPIRAMATE; TRAZODONE; VALPROIC ACID; VENLAFAXINE; ZONISAMIDE;

ADOLESCENT; ADULT; AGED; ARTICLE; DEPRESSION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EXPOSURE; DRUG USE; DRUG WITHDRAWAL; EPILEPSY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOOD; PREDICTOR VARIABLE; SUICIDAL IDEATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTICONVULSANTS; DATABASES, FACTUAL; DEPRESSION; EPILEPSY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SUICIDAL IDEATION; TREATMENT OUTCOME; YOUNG ADULT;

EID: 78649909259     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2010.08.030     Document Type: Article

References (46)

1. World Health Organization. Neurological disorders: public health challenges. Available at: http://www.who.int/mental_health/neurology/neurodiso/en/index.html.
2. Gilliam F., Hecimovic H., Sheline Y. Psychiatric comorbidity, health, and function in epilepsy. Epilepsy Behav 2003, 49(Suppl. 4):S26-S30.
3. Harden C.L. The co-morbidity of depression and epilepsy: epidemiology, etiology, and treatment. Neurology 2002, 59:48-55.
4. Christensen J., Vestergaard M., Mortensen P., Sidenius P., Agerbo E. Epilepsy and risk of suicide: a population-based case-control study. Lancet Neurol 2007, 6:693-698.
5. Jones J.E., Hermann B.P., Barry J.J., Gilliam F.G., Kanner A.M., Meador K.J. Rates and risk factors for suicide, suicidal ideation, and suicide attempts in chronic epilepsy. Epilepsy Behav 2003, 4:S31-S38.
6. Wolfersdorf M., Froescher W. Suizid bei Epilepsiepatienten. Fortschr Neurol Psychiatr 1987, 55:294-298.
7. Barraclough B.M. The suicide rate of epilepsy. Acta Psychiatrica Scand 1987, 76:339-345.
8. Pompili M., Girardi P., Tatarelli G., Angeletti G., Tatarelli R. Suicide after surgical treatment in patients with epilepsy: a meta-analytic investigation. Psychol Rep 2006, 98:323-338.
9. Bell G.S., Mula M., Sander J.W. Suicidality in people taking antiepileptic drugs, what is the evidence?. CNS Drugs 2009, 23:281-292.
10. Hesdorffer D.C., Kanner A.M. The FDA alert on suicidality and antiepileptic drugs: fire or false alarm?. Epilepsia 2009, 50:978-986.
11. Accessed: January 14, 2009. http://www.fda.gov/cder/drug/InfoSheets/HCP/antiepilepticsHCP.htm.
12. Food and Drug Administration, Office of Biostatistics Statistical review and evaluation: antiepileptic drugs and suicidality May 23, 2008, http://www.fda.gov/ohrms/dockets/ac/08/briefing/2008-4372b1-01-FDA.pdf.
13. Roc A. The impact of antiepileptic drugs on suicide risk: an expert interview with Andres Kanner, M.D. Posted: January 26, 2009. Available at: Accessed: January 14, 2009. http://www.medscape.com/viewarticle/587114.
14. Jones J.E., Hermann B.P., Woodard J.L., et al. Screening for major depression in epilepsy with common self-report depression inventories. Epilepsia 2005, 46:731-735.
15. Gilliam F.G., Barry J.J., Hermann B.P., Meador K.J., Vahle V., Kanner A.M. Rapid detection of major depression in epilepsy: a multicentre study. Lancet Neurol 2006, 5:399-405.
16. Valente S.M., Saunders J.M. Management of suicidal patients with HIV disease. J Assoc Nurses AIDS Care 1994, 5(6):19-29.
17. Mula M., Sander J.W. Negative effects of antiepileptic drugs on mood in patients with epilepsy. Drug Saf 2007, 30:555-567.
18. Smith B.D., Salzman C. Do benzodiazepines cause depression?. Hosp Comm Psychiatry 1991, 42:1101-1102.
19. Meador K.J. Cognitive effects of epilepsy and of antiepileptic medications. The treatment of epilepsy: principles & practice 2010, Lippincott Williams & Wilkins, Philadelphia. 5th ed. E. Wyllie, G. Cascino, B. Gidal, H. Goodkin (Eds.).
20. Cramer J.A., Hammer A.E., Kustra R.P. Improved mood states with lamotrigine in patients with epilepsy. Epilepsy Behav 2004, 5:702-707.
21. Cramer J.A., Hammer A.E., Kustra R.P. Quality of life improvement with conversion to lamotrigine monotherapy. Epilepsy Behav 2004, 5:224-230.
22. Kockelmann E., Elger C.E., Helmstaedter C. Cognitive profile of topiramate as compared with lamotrigine in epilepsy patients on antiepileptic drug polytherapy: relationships to blood serum levels and comedication. Epilepsy Behav 2004, 5:716-721.
23. Mula M., Pini S., Cassano G.B. The role of anticonvulsant drugs in anxiety disorders: a critical review of the evidence. J Clin Psychopharmacol 2007, 27:263-272.
24. Carrieri P.B., Provitera V., Iacovitti B., Iachetta C., Nappi C., Indaco A. Mood disorders in epilepsy. Acta Neurol (Napoli) 1993, 15:62-67.
25. Spina E., Perugi G. Antiepileptic drugs: indications other than epilepsy. Epileptic Disord 2004, 6:57-75.
26. Dodrill C.B., Troupin A.S. Psychotropic effects of carbamazepine and phenytoin: a reanalysis. Neurology 1991, 41:141-143.
27. Kalinin V.V., Polyanskiy D.A. Gender and suicidality prediction in epilepsy. Epilepsy Behav 2005, 7:657-663.
28. Rickels K., Pollack M.H., Feltner D.E., et al. Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam. Arch Gen Psychiatry 2005, 62:1022-1030.
29. Vigo D.V., Baldessarini R.J. Anticonvulsants in the treatment of major depressive disorder: an overview. Harv Rev Psychiatry 2009, 17:231-241.
30. Glauser T.A. Behavioral and psychiatric adverse events associated with antiepileptic drugs commonly used in pediatric patients. J Child Neurol 2004, 19(Suppl. 1):S25-S38.
31. Mula M., Trimble M.R., Sander J.W. The role of hippocampal sclerosis in topiramate-related depression and cognitive deficits in people with epilepsy. Epilepsia 2003, 44:1573-1577.
32. Mula M., Trimble M.R., Lhatoo S.D., et al. Topiramate and psychiatric adverse events in patients with epilepsy. Epilepsia 2003, 44:659-663.
33. Shorvon S.D. Safety of topiramate: adverse events and relationship to dosing. Epilepsia 1996, 37(Suppl. 2):18-22.
34. Gareri P., Falconi U., De Fazio P., De Sarro G. Conventional and new antidepressant drugs in the elderly. Prog Neurobiol 2000, 61:353-396.
35. Cramer J.A., Van Hammee G. Maintenance of improvement in health-related quality of life during long-term treatment with levetiracetam. Epilepsy Behav 2003, 4:118-123. for the N132 Study Group.
36. French J., Edrich P., Cramer J. A systematic review of the safety profile of levetiracetam: a new antiepileptic drug. Epilepsy Res 2001, 47:77-90.
37. Mula M., Sander J.W. Suicide ideation in epilepsy and levetiracetam therapy. Epilepsy Behav 2007, 11:130-132.
38. Kanner A.M. Epilepsy, suicidal behavior, and depression: do they share common pathogenic mechanisms?. Lancet Neurol 2006, 5:107-108.
39. Hesdorffer D.C., Hauser W.A., Ludvigsson P., Olafsson E., Kjartansson O. Depression and attempted suicide as risk factors for incident unprovoked seizures and epilepsy. Ann Neurol 2006, 59:35-41.
40. Hesdorffer D.C., Hauser W.A., Olafsson E., Ludvigsson P., Kjartansson O. Epilepsy and suicide risk. Lancet Neurol 2007, 6:847.
41. Olesen J.B., Hansen P.R., Erdal J., et al. Antiepileptic drugs and risk of suicide: a nationwide study. Pharmacoepidemiology Drug Saf 2010, 19:518-524.
42. VanCott A.C., Cramer J.A., Copeland L.A., et al. Suicide-related behaviors in older patients with new anti-epileptic drug use: data from the VA hospital system. BMC Med 2010, 8:4.
43. Patorno E., Bohn R.L., Wahl P.M., Avorn J., Patrick A.R., Liu J., Schneeweiss S. Anticonvulsant medications and the risk of suicide, attempted suicide, or violent death. JAMA 2010, 303:1401-1409.
44. Andersohn F., Schade R., Willich S.N., Garbe E. Use of antiepileptic drugs in epilepsy and the risk of self-harm or suicidal behavior. Neurology 2010, 75:335-340.
45. Arana A., Wentworth C.E., Ayuso-Mateos J.L., Arellano F.M. Suicide-related events in patients treated with antiepileptic drugs. N Engl J Med 2010, 363:542-551.
46. Schneeweiss S., Avorn J. A review of uses of health care utilization databases for epidemiologic research on therapeutics. J Clin Epidemiol 2005, 58:323-337.